Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.66 USD | -4.55% | -16.89% | -32.86% |
05-16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.86% | 364M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Replimune Group's Fiscal Q4 Net Loss Widens; Chief Financial Officer Jean Franchi to Depart